PMID: 42495454

Evaluating the Cardiovascular Benefits of Innovator Semaglutide 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence.

Teli Brij, Sathe Sunil, Kalra Ravi, Mahajan Vivek, Mehta Ajit, Shinde Rituprana, Kunwar Brijesh, Kahale Pravin R, Sinkar Amit, Palimkar Priya

Cureus · 2026

Vol. 18, Issue 6, pp. e111322

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.